Weekly equity research · United States
Momentum Intelligence
Strength that extends beyond one good week.
Find positive momentum shared across time periods, then weigh the consistency of the rise against its volatility.
Showing the completed 18 Sep 2026 edition. The 25 Sep 2026 update is not yet published; these are earlier readings.
Participation across time · full US equity edition
How widely is momentum shared?
Compare the share advancing over each horizon. Short-term strength with weak longer horizons points to a recovery still finding support.
View participation counts
| Horizon | Positive | Flat | Negative |
|---|---|---|---|
| 1 month | 1,046 | 516 | 3,070 |
| 3 months | 2,026 | 227 | 2,379 |
| 6 months | 2,666 | 138 | 1,828 |
| 12 months | 2,351 | 86 | 2,195 |
The screener
Find the strongest complete profiles
United States · 18 Sep 2026
| Equity | Momentum strength | Price returns | Path & agreement | Risk context |
|---|---|---|---|---|
1 ATRC AtriCure IncWeekly chart ↗ |
97.6 /100Broad & orderly | 1m+18.6% 3m+101.7% 6m+99.1% 12m+59.5% |
Orderly4 of 4 horizons positive98% path efficiency · 12 of 13 weeks up | 33.3%Annualised weekly volatility0.0%From 52-week closing high |
2 TXG 10X Genomics IncWeekly chart ↗ |
97.4 /100Broad & orderly | 1m+17.6% 3m+120.4% 6m+316.5% 12m+487.4% |
Orderly4 of 4 horizons positive88% path efficiency · 12 of 13 weeks up | 56.8%Annualised weekly volatility0.0%From 52-week closing high |
3 CON Concentra Group Holdings Parent, Inc.Weekly chart ↗ |
93.3 /100Broad & orderly | 1m+1.3% 3m+24.2% 6m+64.2% 12m+73.1% |
Orderly4 of 4 horizons positive72% path efficiency · 9 of 13 weeks up | 25.2%Annualised weekly volatility0.0%From 52-week closing high |
4 CDNA CareDx IncWeekly chart ↗ |
93.2 /100Broad & orderly | 1m+10.7% 3m+105.6% 6m+213.9% 12m+269.0% |
Orderly4 of 4 horizons positive73% path efficiency · 9 of 13 weeks up | 72.4%Annualised weekly volatility0.0%From 52-week closing high |
5 AVAH Aveanna Healthcare Holdings IncWeekly chart ↗ |
92.5 /100Broad & orderly | 1m+3.9% 3m+75.5% 6m+109.7% 12m+68.8% |
Orderly4 of 4 horizons positive82% path efficiency · 9 of 13 weeks up | 49.5%Annualised weekly volatility-2.9%From 52-week closing high |
6 AVTR Avantor IncWeekly chart ↗ |
91.5 /100Broad & orderly | 1m+7.3% 3m+62.0% 6m+106.7% 12m+24.2% |
Orderly4 of 4 horizons positive91% path efficiency · 11 of 13 weeks up | 38.7%Annualised weekly volatility0.0%From 52-week closing high |
7 IQV IQVIA Holdings IncWeekly chart ↗ |
90.9 /100Broad & orderly | 1m+2.5% 3m+58.8% 6m+60.4% 12m+42.3% |
Orderly4 of 4 horizons positive86% path efficiency · 10 of 13 weeks up | 41.7%Annualised weekly volatility-0.5%From 52-week closing high |
8 IOVA Iovance Biotherapeutics IncWeekly chart ↗ |
90.3 /100Broad & orderly | 1m+23.6% 3m+162.1% 6m+177.8% 12m+400.0% |
Orderly4 of 4 horizons positive63% path efficiency · 8 of 13 weeks up | 87.0%Annualised weekly volatility0.0%From 52-week closing high |
9 PLSE Pulse Biosciences IncWeekly chart ↗ |
90.3 /100Broad & orderly | 1m+6.8% 3m+110.4% 6m+143.8% 12m+205.9% |
Orderly4 of 4 horizons positive69% path efficiency · 10 of 13 weeks up | 77.0%Annualised weekly volatility0.0%From 52-week closing high |
10 NTRA Natera IncWeekly chart ↗ |
89.8 /100Broad & orderly | 1m+11.3% 3m+59.6% 6m+89.2% 12m+104.0% |
Orderly4 of 4 horizons positive65% path efficiency · 9 of 13 weeks up | 50.2%Annualised weekly volatility0.0%From 52-week closing high |
11 ADPT Adaptive Biotechnologies CorpWeekly chart ↗ |
89.7 /100Broad & orderly | 1m+10.1% 3m+63.2% 6m+110.7% 12m+114.1% |
Orderly4 of 4 horizons positive68% path efficiency · 7 of 13 weeks up | 58.7%Annualised weekly volatility0.0%From 52-week closing high |
12 RVTY Revvity Inc.Weekly chart ↗ |
89.6 /100Broad & orderly | 1m+15.0% 3m+43.5% 6m+67.0% 12m+65.8% |
Orderly4 of 4 horizons positive70% path efficiency · 10 of 13 weeks up | 41.5%Annualised weekly volatility0.0%From 52-week closing high |
13 GMAB Genmab ASWeekly chart ↗ |
89.5 /100Broad & orderly | 1m+3.9% 3m+37.5% 6m+38.4% 12m+22.8% |
Orderly4 of 4 horizons positive76% path efficiency · 9 of 13 weeks up | 25.4%Annualised weekly volatility0.0%From 52-week closing high |
14 MNOV MediciNova IncWeekly chart ↗ |
89.5 /100Broad & orderly | 1m+138.8% 3m+151.5% 6m+112.8% 12m+161.4% |
Orderly4 of 4 horizons positive82% path efficiency · 8 of 13 weeks up | 91.8%Annualised weekly volatility0.0%From 52-week closing high |
15 TMO Thermo Fisher Scientific IncWeekly chart ↗ |
89.4 /100Broad & orderly | 1m+3.6% 3m+40.2% 6m+37.5% 12m+36.2% |
Orderly4 of 4 horizons positive80% path efficiency · 9 of 13 weeks up | 33.0%Annualised weekly volatility0.0%From 52-week closing high |
16 NEO NeoGenomics IncWeekly chart ↗ |
89.4 /100Broad & orderly | 1m+17.3% 3m+78.9% 6m+150.1% 12m+133.7% |
Orderly4 of 4 horizons positive59% path efficiency · 8 of 13 weeks up | 59.0%Annualised weekly volatility0.0%From 52-week closing high |
17 ANL Adlai Nortye Ltd. American Depositary SharesWeekly chart ↗ |
89.3 /100Broad & orderly | 1m+14.9% 3m+55.8% 6m+112.7% 12m+791.2% |
Orderly4 of 4 horizons positive78% path efficiency · 10 of 13 weeks up | 90.4%Annualised weekly volatility-1.7%From 52-week closing high |
18 TWST Twist Bioscience CorpWeekly chart ↗ |
89.3 /100Broad & orderly | 1m+14.7% 3m+90.7% 6m+296.9% 12m+498.7% |
Orderly4 of 4 horizons positive53% path efficiency · 8 of 13 weeks up | 80.1%Annualised weekly volatility0.0%From 52-week closing high |
19 ILMN Illumina IncWeekly chart ↗ |
88.8 /100Broad & orderly | 1m+9.2% 3m+48.0% 6m+92.7% 12m+133.2% |
Orderly4 of 4 horizons positive52% path efficiency · 9 of 13 weeks up | 44.6%Annualised weekly volatility0.0%From 52-week closing high |
20 DRTS Alpha Tau Medical LtdWeekly chart ↗ |
87.9 /100Broad & orderly | 1m+2.1% 3m+55.8% 6m+115.6% 12m+272.6% |
Orderly4 of 4 horizons positive48% path efficiency · 8 of 13 weeks up | 55.6%Annualised weekly volatility0.0%From 52-week closing high |
21 HALO Halozyme Therapeutics IncWeekly chart ↗ |
87.6 /100Broad & orderly | 1m+4.0% 3m+64.0% 6m+77.3% 12m+44.5% |
Orderly4 of 4 horizons positive64% path efficiency · 9 of 13 weeks up | 42.1%Annualised weekly volatility0.0%From 52-week closing high |
22 HAE Haemonetics CorporationWeekly chart ↗ |
86.6 /100Broad & orderly | 1m-0.4% 3m+46.2% 6m+85.0% 12m+114.2% |
Orderly3 of 4 horizons positive69% path efficiency · 9 of 13 weeks up | 43.4%Annualised weekly volatility-0.4%From 52-week closing high |
23 ITGR Integer Holdings CorpWeekly chart ↗ |
85.7 /100Broad & orderly | 1m+0.9% 3m+38.8% 6m+50.2% 12m+22.2% |
Orderly3 of 4 horizons positive89% path efficiency · 9 of 13 weeks up | 31.8%Annualised weekly volatility-0.2%From 52-week closing high |
24 BDSX Biodesix IncWeekly chart ↗ |
85.6 /100Broad & orderly | 1m+9.7% 3m+73.7% 6m+96.3% 12m+309.5% |
Orderly4 of 4 horizons positive57% path efficiency · 8 of 13 weeks up | 83.0%Annualised weekly volatility0.0%From 52-week closing high |
25 ROIV Roivant Sciences LtdWeekly chart ↗ |
85.1 /100Broad & orderly | 1m+9.6% 3m+26.5% 6m+43.6% 12m+164.4% |
Orderly4 of 4 horizons positive44% path efficiency · 8 of 13 weeks up | 35.6%Annualised weekly volatility-2.6%From 52-week closing high |
26 SGMT Sagimet Biosciences Inc. Series A Common StockWeekly chart ↗ |
85.0 /100Broad & orderly | 1m+8.2% 3m+66.0% 6m+130.1% 12m+70.1% |
Orderly4 of 4 horizons positive60% path efficiency · 9 of 13 weeks up | 67.8%Annualised weekly volatility0.0%From 52-week closing high |
27 CRON Cronos Group IncWeekly chart ↗ |
84.9 /100Broad & orderly | 1m+1.2% 3m+23.6% 6m+40.2% 12m+27.9% |
Orderly4 of 4 horizons positive48% path efficiency · 10 of 13 weeks up | 24.4%Annualised weekly volatility-0.9%From 52-week closing high |
28 NEOG Neogen CorporationWeekly chart ↗ |
84.6 /100Broad & orderly | 1m+8.8% 3m+39.6% 6m+55.5% 12m+131.7% |
Orderly4 of 4 horizons positive47% path efficiency · 8 of 13 weeks up | 47.0%Annualised weekly volatility0.0%From 52-week closing high |
29 SMTI Sanara Medtech IncWeekly chart ↗ |
84.5 /100Broad & orderly | 1m+1.8% 3m+59.3% 6m+90.8% 12m+6.6% |
Orderly4 of 4 horizons positive85% path efficiency · 12 of 13 weeks up | 60.8%Annualised weekly volatility0.0%From 52-week closing high |
30 PBYI Puma Biotechnology IncWeekly chart ↗ |
84.4 /100Broad & orderly | 1m+3.9% 3m+27.0% 6m+56.9% 12m+117.2% |
Orderly4 of 4 horizons positive40% path efficiency · 7 of 13 weeks up | 38.2%Annualised weekly volatility0.0%From 52-week closing high |
Strength scores use the full eligible United States equity edition, so changing a filter does not change a stock’s score. Returns exclude dividends. Listing country does not establish business exposure.
A transparent ranking
Strong returns, with context
60% · Adjusted strength
Three-, six- and twelve-month log returns are divided by weekly volatility scaled to each horizon. Each is ranked within the country’s complete equity edition, then the three percentile ranks are averaged. Ties share a rank.
20% · Horizon agreement
Each of the four returns above +1% contributes five points. The default leader screen requires at least three positive horizons, a three-month return above +1% and a one-month return no lower than −1%.
20% · Path quality
Over thirteen weeks, net log-price progress is divided by total absolute weekly movement. A more direct path scores higher. The leader screen requires at least 35% efficiency; direction is checked separately.
Risk remains visible
Volatility uses the latest 26 weekly log returns, annualised. A 5% floor is used only in the ranking denominator. The displayed volatility is unchanged. Drawdown measures the distance from the 52-week closing high.
Coverage, publication and limitations
These weights are an explicit research ranking, not a fitted prediction, validated strategy or probability of success. Horizons overlap and are not independent evidence. Large returns may still be stretched; low volatility does not guarantee safety. The ranking does not filter for liquidity or company fundamentals.
Active equity listings use saved, complete weekly Momentum Intelligence profiles. Incomplete, inconsistent or non-finite inputs are excluded, never filled with zero. Cross-listings are separate observations; returns are in each listing’s currency and exclude dividends, fees and taxes. Weekly replacements become visible only when complete; the previous edition stays available with its date.
Published 25 Sep 2026, 16:26 BST · 4,632 eligible equity profiles in this screen.